TNF and Huntington disease: Second, in interpreting the scant experimental evidence [8] and the results of our study, obestatin treatment theoretically may be useful only in HD patients with high TNF-α levels, whereas this treatment seems to be less effective or even harmful (proatherogenic) in HD patients with low TNF-α levels.